Lv6
2700 积分 2023-05-12 加入
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
10小时前
已完结
Targeting ANGPTL3 by GalNAc-conjugated siRNA ANGsiR10 lowers blood lipids with long-lasting and potent efficacy in mice and monkeys
4天前
已完结
Characterization of six clinical drugs and dietary intervention in the non-obese CDAA-HFD mouse model of MASH and progressive fibrosis
16天前
已完结
Effects of HSD17B13-targeting siRNA-R0737072 on Liver Fibrosis and Steatosis in a mouse model of NASH
21天前
已完结
Therapeutic opportunities for the treatment of NASH with genetically validated targets
21天前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
21天前
已完结
Phase 1 randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction–associated steatohepatitis
21天前
已完结
An Extracellular Humanized IFNAR Immunocompetent Mouse Model for Analyses of Human Interferon Alpha and Subtypes
1个月前
已完结
A novel bispecific inhibitor targeting VEGF and complement system suppressed angiogenesis in model of neovascular age-related macular degeneration
2个月前
已关闭
Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis
2个月前
已完结
皖公网安备34019202002308
